Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

63 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q2 2022.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,628,401 shares of 60,660,421 outstanding shares and own 42% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9,770,773 shares), Sands Capital Ventures, LLC (3,417,075 shares), Deep Track Capital, LP (3,100,000 shares), BlackRock Inc. (2,693,311 shares), GREAT POINT PARTNERS LLC (1,515,000 shares), Laurion Capital Management LP (1,206,548 shares), VANGUARD GROUP INC (635,779 shares), MILLENNIUM MANAGEMENT LLC (587,583 shares), PERCEPTIVE ADVISORS LLC (508,532 shares), and GUARDIAN POINT CAPITAL, LP (500,000 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.